Catalyst Wire Dossier Catalyst Wire Dossier

DLQ01

· Dermaliq Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DLQ01, covering 2024-04-08 to 2024-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men [Phase 1, Phase 2]

See pricing